Several short-term and long-term clinical trials have shown that the addition of pramlintide to preexisting insulin therapy improved postprandial and overall glycemic control (hemoglobin A 1c ...
Purpose: The pharmacokinetics, pharmacodynamics, and safety of pramlintide and various insulin formulations in patients with type 1 diabetes mellitus (DM) when given as separate injections or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback